[{"id":5440,"run_id":242,"as_of":"2026-08-22","ticker":"KURA","company":"Kura Oncology, Inc.","source":"weekly","conviction":62.7,"technical":77.8,"stage":"Mature Trend","gated":true,"n_gates":1,"gates":["Overlapping range behaviour — efficiency ratio 0.09 vs the 0.15 threshold (genuine chop)."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":11.89,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":17.0,"Volatility behaviour":12.5,"Cross-asset confirmation":13.6,"Sponsorship / positioning":19.1,"Catalyst alignment (insider)":0.5},"total_cfo_value":0.0,"total_other_value":1112000.0,"n_cfo_buys":0.0,"n_other_buys":1.0,"has_cfo_buy":false,"roles_buying":"1 CEO","npr":-0.1099474973076312,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-22T14:49:55.536534+00:00"},{"id":5532,"run_id":256,"as_of":"2026-08-24","ticker":"KURA","company":"Kura Oncology, Inc.","source":"weekly","conviction":65.8,"technical":79.5,"stage":"Mature Trend","gated":true,"n_gates":1,"gates":["Overlapping range behaviour — efficiency ratio 0.14 vs the 0.15 threshold (borderline, watch for resolution)."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":12.4,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":17.0,"Volatility behaviour":12.5,"Cross-asset confirmation":14.7,"Sponsorship / positioning":19.4,"Catalyst alignment (insider)":2.2},"total_cfo_value":0.0,"total_other_value":2351000.0,"n_cfo_buys":0.0,"n_other_buys":2.0,"has_cfo_buy":false,"roles_buying":"2 CEO","npr":0.24083230238518474,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-24T13:43:37.609921+00:00"},{"id":6235,"run_id":270,"as_of":"2026-08-25","ticker":"KURA","company":"Kura Oncology, Inc.","source":"weekly","conviction":67.2,"technical":81.2,"stage":"Mature Trend","gated":false,"n_gates":0,"gates":[],"sizing_low":17500.0,"sizing_high":24500.0,"sizing_label":"Standard","close":13.59,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":17.6,"Volatility behaviour":12.5,"Cross-asset confirmation":15.3,"Sponsorship / positioning":19.6,"Catalyst alignment (insider)":2.2},"total_cfo_value":0.0,"total_other_value":2351000.0,"n_cfo_buys":0.0,"n_other_buys":2.0,"has_cfo_buy":false,"roles_buying":"2 CEO","npr":0.24083230238518474,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-25T16:51:35.628977+00:00"},{"id":6995,"run_id":309,"as_of":"2026-08-26","ticker":"KURA","company":"Kura Oncology, Inc.","source":"weekly","conviction":68.2,"technical":82.5,"stage":"Mature Trend","gated":false,"n_gates":0,"gates":[],"sizing_low":17500.0,"sizing_high":24500.0,"sizing_label":"Standard","close":13.06,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":18.4,"Volatility behaviour":12.5,"Cross-asset confirmation":15.2,"Sponsorship / positioning":19.9,"Catalyst alignment (insider)":2.2},"total_cfo_value":0.0,"total_other_value":2351000.0,"n_cfo_buys":0.0,"n_other_buys":2.0,"has_cfo_buy":false,"roles_buying":"2 CEO","npr":0.24083230238518474,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-26T20:44:22.189017+00:00"},{"id":7746,"run_id":390,"as_of":"2026-08-27","ticker":"KURA","company":"Kura Oncology, Inc.","source":"weekly","conviction":67.5,"technical":81.6,"stage":"Mature Trend","gated":false,"n_gates":0,"gates":[],"sizing_low":17500.0,"sizing_high":24500.0,"sizing_label":"Standard","close":13.18,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":18.6,"Volatility behaviour":12.5,"Cross-asset confirmation":14.2,"Sponsorship / positioning":20.0,"Catalyst alignment (insider)":2.2},"total_cfo_value":0.0,"total_other_value":2351000.0,"n_cfo_buys":0.0,"n_other_buys":2.0,"has_cfo_buy":false,"roles_buying":"2 CEO","npr":0.24083230238518474,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-27T20:17:55.852107+00:00"},{"id":8361,"run_id":411,"as_of":"2026-08-28","ticker":"KURA","company":"Kura Oncology, Inc.","source":"weekly","conviction":67.4,"technical":81.5,"stage":"Mature Trend","gated":false,"n_gates":0,"gates":[],"sizing_low":17500.0,"sizing_high":24500.0,"sizing_label":"Standard","close":13.18,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":18.6,"Volatility behaviour":12.5,"Cross-asset confirmation":14.1,"Sponsorship / positioning":20.0,"Catalyst alignment (insider)":2.2},"total_cfo_value":0.0,"total_other_value":2351000.0,"n_cfo_buys":0.0,"n_other_buys":2.0,"has_cfo_buy":false,"roles_buying":"2 CEO","npr":0.24083230238518474,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-29T11:54:20.316176+00:00"},{"id":8965,"run_id":413,"as_of":"2026-08-30","ticker":"KURA","company":"Kura Oncology, Inc.","source":"weekly","conviction":60.0,"technical":72.2,"stage":"Mature Trend","gated":false,"n_gates":0,"gates":[],"sizing_low":17500.0,"sizing_high":24500.0,"sizing_label":"Standard","close":12.66,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":18.3,"Volatility behaviour":12.5,"Cross-asset confirmation":13.0,"Sponsorship / positioning":14.0,"Catalyst alignment (insider)":2.2},"total_cfo_value":0.0,"total_other_value":2351000.0,"n_cfo_buys":0.0,"n_other_buys":2.0,"has_cfo_buy":false,"roles_buying":"2 CEO","npr":0.24083230238518474,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-30T01:15:14.903614+00:00"},{"id":9057,"run_id":414,"as_of":"2026-08-31","ticker":"KURA","company":"Kura Oncology, Inc.","source":"weekly","conviction":60.4,"technical":72.8,"stage":"Mature Trend","gated":false,"n_gates":0,"gates":[],"sizing_low":17500.0,"sizing_high":24500.0,"sizing_label":"Standard","close":12.65,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":18.2,"Volatility behaviour":12.5,"Cross-asset confirmation":13.5,"Sponsorship / positioning":14.0,"Catalyst alignment (insider)":2.2},"total_cfo_value":0.0,"total_other_value":2351000.0,"n_cfo_buys":0.0,"n_other_buys":2.0,"has_cfo_buy":false,"roles_buying":"2 CEO","npr":0.24083230238518474,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-31T21:22:03.535773+00:00"},{"id":9653,"run_id":417,"as_of":"2026-09-01","ticker":"KURA","company":"Kura Oncology, Inc.","source":"weekly","conviction":61.6,"technical":74.2,"stage":"Mature Trend","gated":false,"n_gates":0,"gates":[],"sizing_low":17500.0,"sizing_high":24500.0,"sizing_label":"Standard","close":12.89,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":12.5,"Cross-asset confirmation":14.4,"Sponsorship / positioning":14.0,"Catalyst alignment (insider)":2.2},"total_cfo_value":0.0,"total_other_value":2351000.0,"n_cfo_buys":0.0,"n_other_buys":2.0,"has_cfo_buy":false,"roles_buying":"2 CEO","npr":0.24083230238518474,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-09-01T21:37:53.063049+00:00"},{"id":9743,"run_id":418,"as_of":"2026-09-02","ticker":"KURA","company":"Kura Oncology, Inc.","source":"weekly","conviction":62.4,"technical":75.2,"stage":"Mature Trend","gated":false,"n_gates":0,"gates":[],"sizing_low":17500.0,"sizing_high":24500.0,"sizing_label":"Standard","close":13.11,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":18.9,"Volatility behaviour":12.5,"Cross-asset confirmation":14.8,"Sponsorship / positioning":14.0,"Catalyst alignment (insider)":2.2},"total_cfo_value":0.0,"total_other_value":2351000.0,"n_cfo_buys":0.0,"n_other_buys":2.0,"has_cfo_buy":false,"roles_buying":"2 CEO","npr":0.24083230238518474,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-09-02T21:23:53.374859+00:00"}]